Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study
CLINICAL RHEUMATOLOGY, cilt.40, sa.10, ss.4071-4079, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 40 Sayı: 10
- Basım Tarihi: 2021
- Doi Numarası: 10.1007/s10067-021-05785-6
- Dergi Adı: CLINICAL RHEUMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.4071-4079
- Anahtar Kelimeler: Cyclophosphamide, Rituximab, Systemic sclerosis-related interstitial lung diseases
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
Objectives To compare the effectiveness of cyclophosphamide and rituximab in the treatment of patients with systemic sclerosis with pulmonary involvement (SSc-ILD).